Wyriclav™-LB 625 Tablets is an advanced broad-spectrum antibiotic plus probiotic combination designed to effectively treat bacterial infections while maintaining gut flora balance. It combines Amoxycillin and Potassium Clavulanate for enhanced antibacterial coverage along with Lactic Acid Bacillus, which helps reduce antibiotic-associated diarrhea and gastrointestinal disturbances.
This formulation is suitable for adult patients and is widely prescribed for infections caused by beta-lactamase-producing organisms.
Composition (Per Film-Coated Tablet):
-
Amoxycillin Trihydrate I.P.
Equivalent to Amoxycillin 500 mg -
Potassium Clavulanate Diluted I.P.
Equivalent to Clavulanic Acid 125 mg -
Lactic Acid Bacillus
60 Million Spores -
Excipients q.s.
-
Colour: Titanium Dioxide I.P.
Mechanism of Action:
-
Amoxycillin inhibits bacterial cell wall synthesis, causing bacterial cell death.
-
Clavulanic Acid inhibits beta-lactamase enzymes, restoring Amoxycillin activity against resistant bacteria.
-
Lactic Acid Bacillus replenishes beneficial gut flora, improving tolerability and reducing GI side effects.
Indications / Uses:
-
Respiratory tract infections
-
ENT infections
-
Urinary tract infections
-
Skin and soft tissue infections
-
Dental infections
-
Gastrointestinal infections associated with bacterial pathogens
-
Prevention of antibiotic-associated diarrhea
Dosage & Administration:
-
Dosage as directed by the Physician
-
To be taken preferably after food
Storage:
-
Store in a cool, dry and dark place
-
Protect from light and moisture
-
Keep out of reach of children
Warnings & Precautions:
-
Schedule H Prescription Drug
-
Not to be sold without the prescription of a Registered Medical Practitioner
-
Complete the full course of therapy as prescribed
Pack Details:
-
Strength: 625 mg Tablet
-
Dosage Form: Film-coated tablet
-
Packing: 10 × 10 Tablets
-
Route: Oral
Reviews
There are no reviews yet.